07:32 AM EST, 11/14/2025 (MT Newswires) -- Scholar Rock ( SRRK ) reported a Q3 net loss Friday of $0.90 per diluted share, widening from its net loss of $0.66 a year earlier.

Analysts polled by FactSet expected a net loss of $0.84.

The biopharmaceutical company said it had $369.6 million in cash, cash equivalents, and marketable securities as of Sept. 30. The company expects its current cash position to fund operations into 2027.

Shares of the company were up nearly 7% in recent Friday premarket activity.